Ken Griffin Silo Pharma, Inc. Call Options Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SILO
# of Institutions
13Shares Held
338KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny227KShares$186,1440.0% of portfolio
-
Geode Capital Management, LLC Boston, MA30.8KShares$25,2240.0% of portfolio
-
Virtu Financial LLC New York, NY25.6KShares$21,0040.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.3KShares$13,3930.0% of portfolio
-
State Street Corp Boston, MA12.5KShares$10,2500.0% of portfolio
About Silo Pharma, Inc.
- Ticker SILO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,137,910
- Market Cap $2.57M
- Description
- Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...